These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 25224959

  • 1. BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity.
    Cao Y, Slaney CY, Bidwell BN, Parker BS, Johnstone CN, Rautela J, Eckhardt BL, Anderson RL.
    Cancer Res; 2014 Sep 15; 74(18):5091-102. PubMed ID: 25224959
    [Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production.
    Chafe SC, Lou Y, Sceneay J, Vallejo M, Hamilton MJ, McDonald PC, Bennewith KL, Möller A, Dedhar S.
    Cancer Res; 2015 Mar 15; 75(6):996-1008. PubMed ID: 25623234
    [Abstract] [Full Text] [Related]

  • 3. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X, Li B, Li X, Zhao X, Wan L, Lin G, Yu M, Wang J, Jiang X, Feng W, Qin Z, Yin B, Li Z.
    J Immunol; 2014 Feb 01; 192(3):1320-31. PubMed ID: 24379122
    [Abstract] [Full Text] [Related]

  • 4. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J, Du W, Yan F, Wang Y, Li H, Cao S, Yu W, Shen C, Liu J, Ren X.
    J Immunol; 2013 Apr 01; 190(7):3783-97. PubMed ID: 23440412
    [Abstract] [Full Text] [Related]

  • 5. Osteopontin shapes immunosuppression in the metastatic niche.
    Sangaletti S, Tripodo C, Sandri S, Torselli I, Vitali C, Ratti C, Botti L, Burocchi A, Porcasi R, Tomirotti A, Colombo MP, Chiodoni C.
    Cancer Res; 2014 Sep 01; 74(17):4706-19. PubMed ID: 25035397
    [Abstract] [Full Text] [Related]

  • 6. Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.
    Drews-Elger K, Iorns E, Dias A, Miller P, Ward TM, Dean S, Clarke J, Campion-Flora A, Rodrigues DN, Reis-Filho JS, Rae JM, Thomas D, Berry D, El-Ashry D, Lippman ME.
    Breast Cancer Res Treat; 2014 Nov 01; 148(1):41-59. PubMed ID: 25270120
    [Abstract] [Full Text] [Related]

  • 7. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ, Bosiljcic M, Lepard NE, Halvorsen EC, Ho VW, Banáth JP, Krystal G, Bennewith KL.
    J Immunol; 2014 Jan 01; 192(1):512-22. PubMed ID: 24285836
    [Abstract] [Full Text] [Related]

  • 8. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE.
    Clin Cancer Res; 2005 Oct 15; 11(20):7490-8. PubMed ID: 16243823
    [Abstract] [Full Text] [Related]

  • 9. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
    Younos I, Donkor M, Hoke T, Dafferner A, Samson H, Westphal S, Talmadge J.
    Int Immunopharmacol; 2011 Jul 15; 11(7):816-26. PubMed ID: 21376153
    [Abstract] [Full Text] [Related]

  • 10. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
    Sangaletti S, Tripodo C, Santangelo A, Castioni N, Portararo P, Gulino A, Botti L, Parenza M, Cappetti B, Orlandi R, Tagliabue E, Chiodoni C, Colombo MP.
    Cell Rep; 2016 Sep 27; 17(1):233-248. PubMed ID: 27681434
    [Abstract] [Full Text] [Related]

  • 11. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
    Oh K, Lee OY, Shon SY, Nam O, Ryu PM, Seo MW, Lee DS.
    Breast Cancer Res; 2013 Sep 27; 15(5):R79. PubMed ID: 24021059
    [Abstract] [Full Text] [Related]

  • 12. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK, Lahue E, Hoke TA, Shafer LR, Coskun U, Solheim JC, Gulen D, Bishay J, Talmadge JE.
    Int Immunopharmacol; 2009 Jul 27; 9(7-8):937-48. PubMed ID: 19362167
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
    Sinha P, Clements VK, Fulton AM, Ostrand-Rosenberg S.
    Cancer Res; 2007 May 01; 67(9):4507-13. PubMed ID: 17483367
    [Abstract] [Full Text] [Related]

  • 18. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.
    Abe F, Dafferner AJ, Donkor M, Westphal SN, Scholar EM, Solheim JC, Singh RK, Hoke TA, Talmadge JE.
    Cancer Immunol Immunother; 2010 Jan 01; 59(1):47-62. PubMed ID: 19449184
    [Abstract] [Full Text] [Related]

  • 19. Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines.
    Ravindranathan S, Nguyen KG, Kurtz SL, Frazier HN, Smith SG, Koppolu BP, Rajaram N, Zaharoff DA.
    Breast Cancer Res; 2018 Oct 22; 20(1):126. PubMed ID: 30348199
    [Abstract] [Full Text] [Related]

  • 20. Deficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cells.
    Yu F, Shi Y, Wang J, Li J, Fan D, Ai W.
    Int J Cancer; 2013 Dec 15; 133(12):2872-83. PubMed ID: 23737434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.